<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmacytimes.com/view/systematic-review-finds-higher-valency-pneumococcal-vaccines-offer-strong-economic-value-for-us-adults</loc>
      <lastmod>2026-11-20T17:45:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T17:45:00Z</news:publication_date>
        <news:title><![CDATA[Systematic Review Finds Higher-Valency Pneumococcal Vaccines Offer Strong Economic Value for US Adults]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/updates-on-glucagon-like-peptide-1-receptor-agonists-for-diabetes-and-obesity</loc>
      <lastmod>2026-11-30T17:56:00.000Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T15:34:04.251Z</news:publication_date>
        <news:title><![CDATA[Updates on Glucagon-Like Peptide-1 Receptor Agonists for Diabetes and Obesity]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacists-field-common-questions-on-otc-cough-and-cold-products-for-older-adults</loc>
      <lastmod>2026-11-20T14:39:34.530Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T14:39:34.530Z</news:publication_date>
        <news:title><![CDATA[Pharmacists’ Field Common Questions on OTC Cough and Cold Products for Older Adults]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/paradigm-and-the-fit-patient-rethinking-induction-intensity-in-aml</loc>
      <lastmod>2026-11-20T14:24:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T14:24:00Z</news:publication_date>
        <news:title><![CDATA[PARADIGM and the Fit Patient: Rethinking Induction Intensity in AML]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/how-brca-testing-shapes-maintenance-therapy-in-pancreatic-cancer</loc>
      <lastmod>2026-11-19T19:58:50.912Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T19:58:50.912Z</news:publication_date>
        <news:title><![CDATA[How BRCA Testing Shapes Maintenance Therapy in Pancreatic Cancer]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/don-t-let-just-in-case-become-just-because-a-guide-for-navigating-delayed-antibiotic-prescriptions-in-pediatric-patients</loc>
      <lastmod>2026-11-19T19:22:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T19:22:00Z</news:publication_date>
        <news:title><![CDATA[Don’t Let “Just in Case” Become “Just Because”: A Guide for Navigating Delayed Antibiotic Prescriptions in Pediatric Patients]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/rebuilding-vaccine-confidence-a-pharmacist-s-field-guide</loc>
      <lastmod>2026-11-19T17:40:45.974Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:40:45.974Z</news:publication_date>
        <news:title><![CDATA[Rebuilding Vaccine Confidence: A Pharmacist’s Field Guide]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/enzyme-replacement-in-pancreatic-cancer-what-pharmacists-should-know</loc>
      <lastmod>2026-11-19T17:34:57.436Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:34:57.436Z</news:publication_date>
        <news:title><![CDATA[Enzyme Replacement in Pancreatic Cancer: What Pharmacists Should Know]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/a-pharmacist-s-checklist-for-coordinating-care</loc>
      <lastmod>2026-11-19T17:26:37.766Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:26:37.766Z</news:publication_date>
        <news:title><![CDATA[A Pharmacist's Checklist for Coordinating Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/male-mice-develop-more-severe-zika-neurological-disease-despite-comparable-viral-loads</loc>
      <lastmod>2026-11-19T17:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Male Mice Develop More Severe Zika Neurological Disease Despite Comparable Viral Loads]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/cemdisiran-approved-as-first-sirna-therapy-for-myasthenia-gravis</loc>
      <lastmod>2026-11-19T15:29:07.907Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T15:29:07.907Z</news:publication_date>
        <news:title><![CDATA[Cemdisiran Approved as First siRNA Therapy for Myasthenia Gravis]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/do-you-have-a-millionaire-mindset-</loc>
      <lastmod>2026-11-19T14:30:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Do You Have a Millionaire Mindset?]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/managing-postpartum-psychosis-through-lithium-based-treatment-screening-and-team-based-care</loc>
      <lastmod>2026-11-19T14:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Managing Postpartum Psychosis Through Lithium-Based Treatment, Screening, and Team-Based Care]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/biomarker-testing-delays-in-nsclc-tissue-liquid-biopsy-and-treatment-start</loc>
      <lastmod>2026-11-19T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Biomarker Testing Delays in NSCLC: Tissue, Liquid Biopsy, and Treatment Start]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/speeding-up-nsclc-treatment-ai-scheduling-subcutaneous-dosing-and-payer-transparency</loc>
      <lastmod>2026-11-19T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Speeding Up NSCLC Treatment: AI Scheduling, Subcutaneous Dosing, and Payer Transparency]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-venglustat-first-treatment-for-neurological-symptoms-of-gd3</loc>
      <lastmod>2026-11-19T15:37:48.731Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T22:05:18.561Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Venglustat, First Treatment for Neurological Symptoms of GD3]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/asra-case-highlights-when-to-reassess-cannabis-use-for-chronic-pain</loc>
      <lastmod>2026-11-18T21:45:37.197Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T21:45:37.197Z</news:publication_date>
        <news:title><![CDATA[ASRA Case Highlights When to Reassess Cannabis Use for Chronic Pain ]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/from-awareness-to-action-pharmacists-advancing-antibiotic-stewardship</loc>
      <lastmod>2026-11-18T21:32:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T21:32:00Z</news:publication_date>
        <news:title><![CDATA[From Awareness to Action: Pharmacists Advancing Antibiotic Stewardship]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/galinpepimut-s-cuts-risk-of-death-by-41-in-phase-3-regal-trial</loc>
      <lastmod>2026-11-18T21:19:13.411Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T21:19:13.411Z</news:publication_date>
        <news:title><![CDATA[Galinpepimut-S Cuts Risk of Death by 41% in Phase 3 REGAL Trial]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/continuous-glucose-monitoring-for-patient-empowerment-and-medication-optimization</loc>
      <lastmod>2026-11-18T18:46:37.840Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmacy Times</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T18:46:37.840Z</news:publication_date>
        <news:title><![CDATA[Continuous Glucose Monitoring for Patient Empowerment and Medication Optimization]]></news:title>
      </news:news>
	</url></urlset>